WAIKOLOA, Hawaii — The VISA classification system is a helpful tool for monitoring disease progression in patients with thyroid eye disease, according to a speaker here.
At Hawaiian Eye 2026, Mark J. Lucarelli, MD, FACS, said that the VISA system assesses thyroid eye disease (TED) progression by primarily focusing on vision outcomes, inflammatory findings, strabismus and appearance.
“First and foremost, we want to know if there is visual compromise,” he said. “Is there thyroid optic neuropathy, or exposure keratopathy? Second, we’re looking at inflammatory findings.”
VISA implements a 10-point